The Valley Desk

NCT02929498 · Interventional trial

Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Myelodysplastic Syndrome, Myelodysplastic Syndromes

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov